Breaking News
December 11, 2018 - Lund University researchers succeed in obtaining dendritic cells by direct reprogramming
December 11, 2018 - Breast tumors recruit bone marrow cells to boost their growth, study reveals
December 11, 2018 - Updated breast cancer screening guideline highlights importance of shared decision-making
December 11, 2018 - EHR-related stress associated with physician burnout
December 11, 2018 - AHA: 12-Year-Old Heart Defect Survivor Inspires NFL Player’s Foundation
December 11, 2018 - Breast cancer patients who take heart drug with trastuzumab have less heart damage
December 11, 2018 - Providing aid to those humans – and animals – affected by the California fires
December 11, 2018 - Even without proof, CBD is finding a niche as a cure-all
December 11, 2018 - Drawing leads to better memory than writing
December 11, 2018 - Researchers report novel findings on plant hormone
December 10, 2018 - A Tale of Two Labels
December 10, 2018 - Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
December 10, 2018 - A 14-year-old explains what it’s like to get a new heart
December 10, 2018 - Team Players Honored with 2018 Baton Awards
December 10, 2018 - Global report highlights how the changing world is affecting children’s physical activity levels
December 10, 2018 - Genes play a role in physical activity and sleep
December 10, 2018 - DDT in Alaskan fish shown to increase risk of cancer
December 10, 2018 - Laws to curb use of cell phones have greatly reduced fatalities for motorcyclists
December 10, 2018 - Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia
December 10, 2018 - University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy
December 10, 2018 - The heartbeat seat: Demoing new well-being technologies in a car
December 10, 2018 - Leading Cancer Researcher to Direct Herbert Irving Comprehensive Cancer Center
December 10, 2018 - Study compares pain-related diagnoses in First Nations and non-First Nations children, youth
December 10, 2018 - Experts address sleep disorders following traumatic brain injury
December 10, 2018 - Scientists find answers to how cancer spreads
December 10, 2018 - Study explores why older people read more slowly
December 10, 2018 - Smart life-collar could save lives of young children
December 10, 2018 - Asbestos found in most NHS hospitals finds BBC inquiry
December 10, 2018 - Researchers use new technique to probe hydrogen bonds
December 10, 2018 - Music improves social communication in autistic children
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Episodic memory tests help in predicting brain atrophy and Alzheimer’s disease
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials

Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials

image_pdfDownload PDFimage_print

Action Points

  • Note that this meta-analysis suggests that increased use of guideline-directed medical therapy in patients undergoing PCI compared to CABG might explain part of the observed benefit of the former therapy.
  • Future studies evaluating CABG, in particular, should be sure to capture medication prescriptions and adherence postoperatively.

Adherence to medical therapy for secondary prevention was generally low in trials comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) and may have even inadvertently given stenting an advantage in these clinical studies, according to a meta-analysis of large clinical trials.

Guideline-directed medical therapy (GDMT) in terms of the combination treatment with antiplatelets, beta-blockers, and statins was prescribed to 67% at year 1 after coronary revascularization and 53% at year 5. Compliance fell even lower — 40% at year 1 and 38% at year 5 — when the recommended treatment list included the use of ACE inhibitors or angiotensin receptor blockers (ARBs).

“Despite the compelling benefits demonstrated by GDMT as secondary prevention after coronary revascularization, compliance remains low even in the tightly controlled environment of clinical trials,” Ana-Catarina Pinho-Gomes, MSc, of Oxford’s John Radcliffe Hospital in England, and colleagues wrote in the Feb. 13 issue of the Journal of the American College of Cardiology.

Notably, adherence to the guidelines was consistently lower after CABG than with PCI. “The difference was particularly marked for P2Y12-receptor inhibitors, as dual antiplatelet therapy is formally recommended in the guidelines after PCI,” the researchers noted.

“The better outcomes achieved with CABG versus PCI became less obvious as the compliance with GDMT increased in PCI versus CABG. Therefore, if compliance rates were identical in both groups, the superiority of CABG for major clinical endpoints might have been even more marked, as part of the benefit of PCI might be explained by better compliance with GDMT,” the investigators suggested.

Their meta-analysis included five trials: SYNTAX, FREEDOM, PRECOMBAT, BEST, and EXCEL.

Pinho-Gomes’ group said that the underuse of GDMT, particularly after CABG, may be related to the misconception that the value of maintaining GDMT is reduced once diseased coronary arteries have been mechanically revascularized with either PCI or CABG.

“In keeping with this, medical therapy is often neglected in coronary revascularization trials and hence poorly reported or not even collected at all, as happened in the recent NOBLE trial,” they pointed out.

“From a research perspective, going forward, clinical investigators must direct their energy toward collecting prescription data in [coronary artery disease] trials and strive to implement GDMT for nearly all study subjects. As leaders in the field and frequent co-authors of guideline statements, revascularization trialists have a responsibility to serve as role models in improving GDMT prescription rates,” said Marc Ruel, MD, MPH, of the University of Ottawa Heart Institute in Ontario, and Alexander Kulik, MD, MPH, of Boca Raton Regional Hospital in Florida.

In an accompanying editorial, Ruel and Kulik suggested that this must be done, even if it means providing trial participants with full coverage for secondary prevention therapy. “Ultimately, improving compliance with GDMT both in and out of the clinical trial context will help our patients achieve the highest level of physical health and quality of life after coronary revascularization,” they said.

Pinho-Gomes and colleagues noted that overall compliance with aspirin and statins was high and reasonably stable over time. There were some differences in antiplatelet prescribing patterns — but considering the controversy regarding dual antiplatelet therapy after coronary revascularization, these differences between trials were not unexpected, either.

It was compliance with beta-blockers and ACE inhibitors or ARBs that was low and more variable, ranging from 43% to 80% and 28% to 79%, respectively, in trials.

“One possible explanation is the fact that although the efficacy of antiplatelet agents and statins in reducing cardiovascular events after coronary revascularization has long been recognized, the advantages of other drug classes have been established more recently and may vary according to comorbidities and risk factors,” the authors suggested.

Limitations of the meta-analysis were that it potentially overestimated medication compliance, because prescriptions were analyzed as a surrogate endpoint; that no patient-level data were available for analysis; and that relatively few trials were included.

Pinho-Gomes and Ruel disclosed no conflicts of interest.

Kulik reported research support from AstraZeneca and Pfizer.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-06-02T00:00:00-0400

last updated

Tagged with:

About author

Related Articles